MeOmics
PrivateLast Round
Angel
Feb 9, 2026
Total Funding Raised
$627,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MeOmics is a biotechnology company that provides a precision psychiatry platform using patient-derived neurons and AI to improve psychiatric drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Mental Health, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MeOmics Comparables
Compare MeOmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Organotics | 83% | |
| NeuroKaire | 79% | |
| Herophilus | 78% |
MeOmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Feb 9, 2026 | ||||
| Pre Seed | May 9, 2022 |
Key People
Founding team and executive leadership
MeOmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angels Invest Wales | Angel |
| Innovate UK | Pre Seed |
| Women Angels of Wales | Angel |
| Welsh Government | Grant |
| Development Bank of Wales | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 123% MoM.
- Jun 25, 2026
Grew 43% QoQ from 7 to 10 employees.
Recent news
Latest coverage and updates
- receives_awardOct 2, 2026
MeOmics Precision Medicine Ltd. received the Innovation in STEM Award
MeOmics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MeOmics's valuation, stock price, and market status.
Is MeOmics a public or private company?
MeOmics is a private company.
What is the current stock price of MeOmics?
MeOmics is a private company, so its shares have no public market price. Caplight tracks MeOmics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MeOmics worth (valuation)?
Valuation information for MeOmics is not publicly available.
Can I buy MeOmics stock?
MeOmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MeOmics's last funding round?
MeOmics's most recent funding round was Angel on February 9, 2026.
Who are the main investors in MeOmics?
Key investors in MeOmics include Women Angels of Wales.
Will MeOmics IPO soon?
No public IPO plans have been announced for MeOmics.
How can I track MeOmics secondary market activity?
Caplight tracks bids, offers, and trades in MeOmics's shares on secondary markets.